Tajikistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.

Press releases published on August 19, 2026

7 hours ago

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Indeterminate GlobeNewswire

7 hours ago

Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

Indeterminate GlobeNewswire

7 hours ago

Medical Tubing Market to Reach USD 19.64 Billion by 2031, at a CAGR of 7.9% — MarketsandMarkets™

Indeterminate GlobeNewswire

7 hours ago

Earth Science Tech, Inc. (ETST) Acquires Zoolzy LLC to Drive Margin Expansion and Strategic Entry into the Veterinary Market

Indeterminate GlobeNewswire

7 hours ago

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Indeterminate GlobeNewswire

7 hours ago

Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

Indeterminate GlobeNewswire

7 hours ago

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Indeterminate GlobeNewswire

7 hours ago

NOMAD Achieves UL 9540 Certification for 1 MW Transportable Battery Energy Storage System

Indeterminate GlobeNewswire

7 hours ago

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

8 hours ago

MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

Indeterminate GlobeNewswire

8 hours ago

AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

8 hours ago

Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026

Indeterminate GlobeNewswire

8 hours ago

Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results

Indeterminate GlobeNewswire

8 hours ago

Atsena Therapeutics Appoints Matt Pauls to Board of Directors

Indeterminate GlobeNewswire

8 hours ago

Sofwave Surpasses One Million Treatments Worldwide; Milestone Treatment Performed in South Korea

Indeterminate GlobeNewswire

8 hours ago

Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care

Indeterminate GlobeNewswire

8 hours ago

SK pharmteco célèbre l’avancement des travaux par une cérémonie d’inauguration de deux sites de production de pointe sur son campus de Swords, en Irlande

Indeterminate GlobeNewswire

8 hours ago

SK pharmteco feiert Baufortschritt mit Eröffnung zweier hochmoderner Produktionsanlagen am Standort Swords, Irland

Indeterminate GlobeNewswire

8 hours ago

Avicanna Announces Closing of Strategic Non-Brokered Private Placement

Indeterminate GlobeNewswire

9 hours ago

TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

Indeterminate GlobeNewswire